IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,113 | -15.0% | 69,900 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,309 | +413.3% | 69,900 | 0.0% | 0.00% | +200.0% |
| Q1 2023 | $255 | -28.2% | 69,900 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $355 | -99.9% | 69,900 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $323,000 | +7.7% | 69,900 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $300,000 | -9.6% | 69,900 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $332,000 | -29.8% | 69,900 | +10.1% | 0.00% | 0.0% |
| Q4 2021 | $473,000 | +35.5% | 63,500 | +2.4% | 0.00% | 0.0% |
| Q3 2021 | $349,000 | -13.0% | 62,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $401,000 | -19.2% | 62,000 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $496,000 | +23.4% | 62,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $402,000 | +117.3% | 62,000 | -31.3% | 0.00% | +100.0% |
| Q2 2019 | $185,000 | -67.1% | 90,200 | +63.7% | 0.00% | -66.7% |
| Q1 2019 | $562,000 | +179.6% | 55,100 | +22.2% | 0.00% | +200.0% |
| Q4 2018 | $201,000 | -64.2% | 45,100 | -18.1% | 0.00% | -66.7% |
| Q3 2018 | $562,000 | -0.4% | 55,100 | -2.7% | 0.00% | -25.0% |
| Q2 2018 | $564,000 | -7.2% | 56,600 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $608,000 | +95.5% | 56,600 | +50.1% | 0.00% | 0.0% |
| Q1 2016 | $311,000 | -48.5% | 37,700 | -14.7% | 0.00% | -42.9% |
| Q4 2015 | $604,000 | +44.8% | 44,200 | +1.8% | 0.01% | +40.0% |
| Q3 2015 | $417,000 | -30.8% | 43,400 | +3.6% | 0.01% | -28.6% |
| Q2 2015 | $603,000 | +67.5% | 41,900 | +4.2% | 0.01% | +75.0% |
| Q1 2015 | $360,000 | +29.5% | 40,200 | -13.0% | 0.00% | 0.0% |
| Q4 2014 | $278,000 | -47.7% | 46,200 | -8.0% | 0.00% | -42.9% |
| Q3 2014 | $532,000 | -8.7% | 50,200 | +2.0% | 0.01% | -22.2% |
| Q2 2014 | $583,000 | -25.6% | 49,200 | -6.3% | 0.01% | -25.0% |
| Q1 2014 | $784,000 | +7.3% | 52,500 | +8.2% | 0.01% | 0.0% |
| Q4 2013 | $731,000 | -9.0% | 48,500 | +2.8% | 0.01% | -14.3% |
| Q3 2013 | $803,000 | – | 47,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
| Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
| Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
| Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
| Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
| Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
| Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
| PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |